GlaxoSmithKline
This article was originally published in The Gray Sheet
Executive Summary
Shipments of Infanrix vaccine in prefilled Tip-Lok syringes begin April 3 following FDA approval via biologics license application supplement. The combination of diphtheria and tetanus toxoids and pertussis antigen vaccine was originally approved in January 1997. The Tip-Lok syringe is manufactured by BD Corp. and filled by GSK. The device is OSHA-compliant for "convenient and time-saving delivery," GSK says. The drug firm also offers Engerix, Havrix and Twinrix vaccines in the Tip-Lok device...
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.